Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression |
University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD |
'A' Award Grants |
2016 |
Texas |
MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors |
Vanderbilt University Medical Center / William Tansey, PhD |
Innovation Grants |
2016 |
Tennessee |
Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome |
St. Jude Children’s Research Hospital / Lisa Jacola, PhD |
Psychosocial Grants |
2016 |
Tennessee |
CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors |
St. Jude Children’s Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD |
Innovation Grants |
2016 |
Tennessee |
Enhancing Coping and Communication in Children with Cancer and Their Parents: A Novel Internet-Based Intervention |
Vanderbilt University Medical Center / Bruce Compas, PhD |
Psychosocial Grants |
2016 |
Tennessee |
CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL |
Children’s Hospital of Philadelphia / Asen Bagashev, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Targeted Combination Therapy to Sensitize High-Risk Acute Lymphoblastic Leukemia to Methotrexate via Restoration of Ikaros Tumor Suppression |
The Pennsylvania State University / Sinisa Dovat, MD/PhD & Chunhua Song, MD/PhD |
Innovation Grants |
2016 |
Pennsylvania |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |